{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T15:33:11Z","timestamp":1790436791044,"version":"4.1.0"},"reference-count":24,"publisher":"Japanese Circulation Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ Rep"],"published-print":{"date-parts":[[2024,7,10]]},"DOI":"10.1253\/circrep.cr-24-0041","type":"journal-article","created":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T22:11:03Z","timestamp":1717798263000},"page":"276-280","source":"Crossref","is-referenced-by-count":2,"title":["Rationale and Design of a Multicenter Trial on Exploratory Analysis of the Effects of Advance Care Planning Guided by the Prediction Program of Heart Failure Prognosis on Quality of Life in Patients With Heart Failure\u3000\u2015 ACQUAINT-Trial \u2015"],"prefix":"10.1253","volume":"6","author":[{"given":"Hiroyuki","family":"Takahama","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"},{"name":"Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kitai","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoko","family":"Nakagawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misa","family":"Takegami","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine and Epidemiology, National Cerebral and Cardiovascular Center"},{"name":"Department of Public Health and Health Policy, School of Medicine, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Hamatani","sequence":"additional","affiliation":[{"name":"Department of Cardiology, National Hospital Organization Kyoto Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Nakamoto","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohito","family":"Ohtani","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junki","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya City University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Shintani","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya City University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Anchi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiyo","family":"Azechi","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukie","family":"Kawano","sequence":"additional","affiliation":[{"name":"Department of Nursing, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuko","family":"Takada","sequence":"additional","affiliation":[{"name":"Department of Nursing, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai","family":"Yumino","sequence":"additional","affiliation":[{"name":"Yumino Medical"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Seo","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya City University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Sakata","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaharu","family":"Akao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, National Hospital Organization Kyoto Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Yasuda","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"},{"name":"Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunihiro","family":"Nishimura","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine and Epidemiology, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chisato","family":"Izumi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Tsutsui H, Isobe M, Ito H, Ito H, Okumura K, Ono M, et al; Japanese Circulation Society and the Japanese Heart Failure Society Joint Working Group. JCS 2017\/JHFS 2017 Guideline on diagnosis and treatment of acute and chronic heart failure: Digest version. <i>Circ J<\/i> 2019; 83: 2084\u20132184.","DOI":"10.1253\/circj.CJ-19-0342"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Bohm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. <i>Eur Heart J<\/i> 2021; 42: 3599\u20133726.","DOI":"10.1093\/eurheartj\/ehab368"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Fernandez-Martinez J, Romero-Correa M, Salamanca-Bautista P, Aramburu-Bodas O, Formiga F, Vazquez-Rodriguez P, et al; EPICTER Investigators group. Prevalence of advanced heart failure and use of palliative care in admitted patients: Findings from the EPICTER study. <i>Int J Cardiol<\/i> 2021; 327: 125\u2013131.","DOI":"10.1016\/j.ijcard.2020.11.002"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Martinez-Selles M, Vidan MT, Lopez-Palop R, Rexach L, Sanchez E, Datino T, et al. End-stage heart disease in the elderly. <i>Rev Esp Cardiol<\/i> 2009; 62: 409\u2013421.","DOI":"10.1016\/S1885-5857(09)71668-8"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Takada Y, Hamatani Y, Kawano Y, Anchi Y, Nakai M, Izumi C, et al. Development and validation of support tools for advance care planning in patients with chronic heart failure. <i>Int J Palliat Nurs<\/i> 2019; 25: 494\u2013502.","DOI":"10.12968\/ijpn.2019.25.10.494"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Takahama H, Izumi C. Palliative care for patients with advanced heart failure: When is the optimal timing of advanced care planning? <i>Int J Cardiol<\/i> 2021; 328: 143\u2013144.","DOI":"10.1016\/j.ijcard.2020.12.004"},{"key":"7","unstructured":"7. Singer PA, Robertson G, Roy DJ. Bioethics for clinicians. 6: Advance care planning. <i>CMAJ<\/i> 1996; 155: 1689\u20131692."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Detering KM, Hancock AD, Reade MC, Silvester W. The impact of advance care planning on end of life care in elderly patients: Randomised controlled trial. <i>BMJ<\/i> 2010; 340: C1345.","DOI":"10.1136\/bmj.c1345"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Anzai T, Sato T, Fukumoto Y, Izumi C, Kizawa Y, Koga M, et al. JCS\/JHFS 2021 Statement on palliative care in cardiovascular diseases. <i>Circ J<\/i> 2021; 85: 695\u2013757.","DOI":"10.1253\/circj.CJ-20-1127"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Levy WC, Mozaffarian D, Linker DT, Sutradhar SC, Anker SD, Cropp AB, et al. The Seattle Heart Failure Model: Prediction of survival in heart failure. <i>Circulation<\/i> 2006; 113: 1424\u20131433.","DOI":"10.1161\/CIRCULATIONAHA.105.584102"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Shiraishi Y, Kohsaka S, Nagai T, Goda A, Mizuno A, Nagatomo Y, et al. Validation and recalibration of Seattle Heart Failure Model in Japanese acute heart failure patients. <i>J Card Fail<\/i> 2019; 25: 561\u2013567.","DOI":"10.1016\/j.cardfail.2018.07.463"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. York MK, Gupta DK, Reynolds CF, Farber-Eger E, Wells QS, Bachmann KN, et al. B-type natriuretic peptide levels and mortality in patients with and without heart failure. <i>J Am Coll Cardiol<\/i> 2018; 71: 2079\u20132088.","DOI":"10.1016\/j.jacc.2018.02.071"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Hamatani Y, Nagai T, Shiraishi Y, Kohsaka S, Nakai M, Nishimura K, et al. Long-term prognostic significance of plasma B-type natriuretic peptide level in patients with acute heart failure with reduced, mid-range, and preserved ejection fractions. <i>Am J Cardiol<\/i> 2018; 121: 731\u2013738.","DOI":"10.1016\/j.amjcard.2017.12.012"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Anegawa E, Takahama H, Nishimura K, Onozuka D, Irie Y, Moriuchi K, et al. Improvements of predictive power of B-type natriuretic peptide on admission by mathematically estimating its discharge levels in hospitalised patients with acute heart failure. <i>Open Heart<\/i> 2021; 8: e001603.","DOI":"10.1136\/openhrt-2021-001603"},{"key":"15","unstructured":"15. Health, Labour and Welfare Ministry, Japan [Survey on awareness regarding medical care at the final stage of life]. https:\/\/www.mhlw.go.jp\/toukei\/list\/saisyuiryo_a.html (accessed April 26, 2022)."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Bo X, Zhang Y, Liu Y, Kharbuja N, Chen L. Performance of the heart failure risk scores in predicting 1 year mortality and short-term readmission of patients. <i>ESC Heart Fail<\/i> 2023; 10: 502\u2013517.","DOI":"10.1002\/ehf2.14208"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Takahama H, Nishimura K, Ahsan B, Hamatani Y, Makino Y, Nakagawa S, et al. Clinical application of artificial intelligence algorithm for prediction of one-year mortality in heart failure patients. <i>Heart Vessels<\/i> 2023, 38: 785\u2013792.","DOI":"10.1007\/s00380-023-02237-w"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Kalogeropoulos AP, Georgiopoulou VV, Giamouzis G, Smith AL, Agha SA, Waheed S, et al. Utility of the Seattle Heart Failure Model in patients with advanced heart failure. <i>J Am Coll Cardiol<\/i> 2009; 53: 334\u2013342.","DOI":"10.1016\/j.jacc.2008.10.023"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Levy WC, Mozaffarian D, Linker DT, Farrar DJ, Miller LW; REMATCH Investigators. Can the Seattle heart failure model be used to risk-stratify heart failure patients for potential left ventricular assist device therapy? <i>J Heart Lung Transplant<\/i> 2009; 28: 231\u2013236.","DOI":"10.1016\/j.healun.2008.12.015"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Mozaffarian D, Anker SD, Anand I, Linker DT, Sullivan MD, Cleland JG, et al. Prediction of mode of death in heart failure: The Seattle Heart Failure Model. <i>Circulation<\/i> 2007; 116: 392\u2013398.","DOI":"10.1161\/CIRCULATIONAHA.106.687103"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Goda A, Williams P, Mancini D, Lund LH. Selecting patients for heart transplantation: Comparison of the Heart Failure Survival Score (HFSS) and the Seattle heart failure model (SHFM). <i>J Heart Lung Transplant<\/i> 2011; 30: 1236\u20131243.","DOI":"10.1016\/j.healun.2011.05.012"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Mehra MR, Canter CE, Hannan MM, Semigran MJ, Uber PA, Baran DA, et al. The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update. <i>J Heart Lung Transplant<\/i> 2016; 35: 1\u201323.","DOI":"10.1016\/j.healun.2015.10.023"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Peterson PN, Rumsfeld JS, Liang L, Albert NM, Hernandez AF, Peterson ED, et al. A validated risk score for in-hospital mortality in patients with heart failure from the American Heart Association get with the guidelines program. <i>Circ Cardiovasc Qual Outcomes<\/i> 2010; 3: 25\u201332.","DOI":"10.1161\/CIRCOUTCOMES.109.854877"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Sartipy U, Dahlstrom U, Edner M, Lund LH. Predicting survival in heart failure: Validation of the MAGGIC heart failure risk score in 51,043 patients from the Swedish heart failure registry. <i>Eur J Heart Fail<\/i> 2014; 16: 173\u2013179.","DOI":"10.1111\/ejhf.32"}],"container-title":["Circulation Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circrep\/6\/7\/6_CR-24-0041\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T03:28:33Z","timestamp":1720841313000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circrep\/6\/7\/6_CR-24-0041\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,10]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1253\/circrep.cr-24-0041","relation":{},"ISSN":["2434-0790"],"issn-type":[{"value":"2434-0790","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,10]]},"article-number":"CR-24-0041"}}